Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-10-06 00:00:00 ET · period of report 2022-10-04 · accession 0001209191-22-053018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-06 | 2022-10-04 | TVTX | Heerma Peter | Chief Commercial Off | S - Sale | $25.68 | -3,042 | 65.1K | -4% | -$78.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-04 | S | D | 3,042 | $25.68 | 65,148 | D | — | — | (F2) Includes 893 shares of the Issuer's common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program. |